RELI Group has partnered with healthcare AI company Basys.ai to help federal agencies use AI safely and effectively while improving health programs and reducing fraud, waste and abuse.
“This partnership reflects our unwavering commitment to innovation with purpose,” said RELI Founder and CEO Mohammad Elias. “By joining forces with Basys.ai, we can equip federal agencies with tools that not only improve efficiency but also uphold the highest standards of integrity.”
Through the partnership, RELI and Basys.ai will combine expertise and advanced technology to improve program integrity and efficiency. Their first joint initiative, SureReview, is an AI-powered medical record review tool built to streamline audits, reduce administrative burden and improve accuracy in healthcare oversight. RELI plans to launch SureReview in 2026 as part of its mission to strengthen healthcare integrity across federal programs.
Basys.ai Co-Founder and CEO Amber Nigam said the partnership aligns closely with the company’s mission.
“At Basys.ai, we believe in building AI that acts with purpose,” she said. “Partnering with RELI Group allows us to bring our agentic AI capabilities to the federal space, where transparency and accountability are paramount. Together, we’re creating solutions like SureReview that empower agencies to make faster, smarter decisions while safeguarding patient data and public resources.”
RELI President and COO Vishal Tulsian said the collaboration ensures technology serves a higher mission.
“AI has immense potential to transform healthcare, but it must be implemented thoughtfully and ethically,” he said. “Our collaboration with Basys.ai ensures that technology serves the mission of protecting public trust, eliminating fraud, waste, and abuse, and delivering measurable value to the agencies we support.”
